Cantabio Pharmaceuticals Inc
OTC:CTBO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cantabio Pharmaceuticals Inc
OTC:CTBO
|
US |
Income Statement
Earnings Waterfall
Cantabio Pharmaceuticals Inc
Income Statement
Cantabio Pharmaceuticals Inc
| Mar-2013 | Jun-2013 | Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||||||||||
| Operating Expenses |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
|
| Selling, General & Administrative |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Operating Income |
(0)
N/A
|
(0)
-50%
|
(0)
-50%
|
(0)
-33%
|
(0)
-9%
|
(0)
+19%
|
(0)
-29%
|
(0)
+11%
|
(0)
+63%
|
(0)
-304%
|
(0)
-100%
|
(0)
-71%
|
(1)
-105%
|
(1)
+2%
|
(1)
-16%
|
(1)
-27%
|
(1)
+12%
|
(1)
-2%
|
(1)
+1%
|
(1)
+5%
|
(1)
-31%
|
(2)
-14%
|
(1)
+19%
|
(1)
-6%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(0)
N/A
|
(0)
-50%
|
(0)
-50%
|
(0)
-33%
|
(0)
-9%
|
(0)
+19%
|
(0)
+57%
|
0
N/A
|
0
+683%
|
(0)
N/A
|
(0)
-850%
|
(0)
-47%
|
(1)
-168%
|
(1)
-22%
|
(1)
-15%
|
(1)
-15%
|
(1)
+9%
|
(1)
-8%
|
(1)
-5%
|
(1)
-19%
|
(2)
-35%
|
(2)
-6%
|
(2)
-10%
|
(2)
+34%
|
|
| Net Income | |||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Net Income (Common) |
(0)
N/A
|
(0)
-50%
|
(0)
-50%
|
(0)
-33%
|
(0)
-9%
|
(0)
+19%
|
(0)
+57%
|
0
N/A
|
0
+683%
|
(0)
N/A
|
(0)
-850%
|
(0)
-47%
|
(1)
-168%
|
(1)
-22%
|
(1)
-15%
|
(1)
-15%
|
(1)
+9%
|
(1)
-8%
|
(1)
-5%
|
(1)
-19%
|
(2)
-35%
|
(2)
-6%
|
(2)
-10%
|
(2)
+34%
|
|
| EPS (Diluted) |
-10.34
N/A
|
-13.36
-29%
|
-16.54
-24%
|
-21.09
-28%
|
-19.03
+10%
|
-14.96
+21%
|
-3
+80%
|
1
N/A
|
26.45
+2 545%
|
-11.71
N/A
|
-67.73
-478%
|
-93.3
-38%
|
-206.4
-121%
|
-92
+55%
|
-106
-15%
|
-122
-15%
|
-207.48
-70%
|
-120
+42%
|
-126
-5%
|
-260.18
-106%
|
-325
-25%
|
-200.84
+38%
|
-200.98
0%
|
-88.32
+56%
|
|